bimatoprost eg 0.1 mg/ml eye drops sol. dropper cont.
eg sa-nv - bimatoprost 0,1 mg/ml - eye drops, solution - 0,1 mg/ml - bimatoprost 0.1 mg/ml - bimatoprost
bimatoprost sandoz 0,3 mg/ml eye drops sol. dropper cont.
sandoz sa-nv - bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml - bimatoprost 0.3 mg/ml - bimatoprost
bimatoprost sandoz 0,1 mg/ml eye drops sol. dropper cont.
sandoz sa-nv - bimatoprost 0,1 mg/ml - eye drops, solution - 0,1 mg/ml - bimatoprost 0.1 mg/ml - bimatoprost
bimatoprost eg 0.3 mg/ml eye drops sol. single-dose cont.
eg sa-nv - bimatoprost 0,3 mg/ml - eye drops, solution in single-dose container - 0,3 mg/ml - bimatoprost 0.3 mg/ml - bimatoprost
bimatoprost bos eye drops, solution
boston oncology arabia, saudi arabia - bimatoprost - eye drops, solution - 0.1 mg/ml,
ganfort eye drops
abbvie pte. ltd. - bimatoprost; timolol maleate 6.8mg/ml eqv. to timolol base - solution, sterile - 0.3mg/ml - bimatoprost 0.3mg/ml; timolol maleate 6.8mg/ml eqv. to timolol base 5mg/ml
lumigan 300microgramsml eye drops 0.4ml unit dose
allergan ltd - bimatoprost - eye drops - 300microgram/1ml
sturiban 0.3mg/ml eye drops
actavis uk ltd - bimatoprost - eye drops - 300microgram/1ml
bimprozt bimatoprost 300 microgram/ml eye drops bottle
arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; benzalkonium chloride; citric acid monohydrate; dibasic sodium phosphate heptahydrate - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.
lumifor bimatoprost 300 microgram/ml eye drops bottle
abbvie pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; dibasic sodium phosphate heptahydrate; sodium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.